miR‐148‐3p and miR‐152‐3p synergistically regulate prostate cancer progression via repressing KLF4
Feng Feng(Shanxi Datong University), Jianjun Huang(Shanghai Children's Hospital), Qinghua Xia(Huazhong University of Science and Technology), Aiping Chen(Nanjing University), Hui Liu(Shandong University), Jin Xun-bo(Shandong University), Yong Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 61
Related Papers
Negative pressure wound therapy improves bone regeneration by promoting osteogenic differentiation via the AMPK-ULK1-autophagy axis
|Autophagy|2021|105
Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer
|Journal of Biological Chemistry|2019|83
The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
|Journal of Experimental & Clinical Cancer Research|2013|75
Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth
|Biochemical Pharmacology|2015|64
Ideal cardiovascular health behaviors and factors prevent the development of hypertension in prehypertensive subjects
|Clinical and Experimental Hypertension|2015|63